CBS 2019
CBSMD教育中心
English

充血性心力衰竭

科研文章

荐读文献

Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions Modifiable lifestyle factors and heart failure: A Mendelian randomization study The prevalence and importance of frailty in heart failure with reduced ejection fraction - an analysis of PARADIGM-HF and ATMOSPHERE The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF) Heart Failure and Atrial Fibrillation, Like Fire and Fury Primary Prevention of Heart Failure in Women Empagliflozin Increases Cardiac Energy Production in Diabetes - Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors Sex- and Race-Related Differences in Characteristics and Outcomes of Hospitalizations for Heart Failure With Preserved Ejection Fraction Dilated cardiomyopathy: so many cardiomyopathies!

Original Research2015 Jan 20;131(3):269-79.

JOURNAL:Circulation. Article Link

Phenomapping for Novel Classification of Heart Failure With Preserved Ejection Fraction

Shah SJ, Katz DH, Selvaraj S et al. Keywords: cluster analysis; echocardiography; heart failure, diastolic; patient outcome assessment

FULL TEXT PDF